HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS		QUICK SEARCH:   [advanced] Author: Keyword(s): Year:  Vol:  Page:

This Article Full Text Full Text (PDF) Alert me when this article is cited Alert me if a correction is posted Citation Map Services Email this article to a friend Similar articles in this journal Similar articles in PubMed Alert me to new issues of the journal Download to citation manager Citing Articles Citing Articles via HighWire Citing Articles via CrossRef Citing Articles via Google Scholar Google Scholar Articles by O'Nions, J. Articles by Allday, M. J. Search for Related Content PubMed PubMed Citation Articles by O'Nions, J. Articles by Allday, M. J. Agricola Articles by O'Nions, J. Articles by Allday, M. J.

Proliferation and differentiation in isogenic populations of peripheral B cells activated by Epstein–Barr virus or T cell-derived mitogens

Department of Virology and Ludwig Institute for Cancer Research, Wright–Fleming Institute, Faculty of Medicine, Imperial College London, Norfolk Place, London W2 1PG, UK

Correspondence
Martin J. Allday
m.allday{at}imperial.ac.uk

Human B cells isolated from peripheral blood were activated and induced to proliferate by either Epstein–Barr virus (EBV) or the T cell-derived mitogens CD40 ligand (CD40L) plus interleukin (IL)-4. Although both populations initially proliferated as B-blasts, significant differences were revealed over a longer period. EBV infection resulted in continuously proliferating lymphoblastoid cell lines (LCLs), whereas most of the CD40L/IL-4-stimulated B cells had a finite proliferative lifespan of 3–4 weeks. Cell cycle analysis, trypan blue staining and Western blot analysis for cleavage of poly(ADP-ribose) polymerase (PARP) all demonstrated that the decrease in proliferation in CD40L/IL-4-stimulated B cells is not due to cell death. Instead, these cells arrest, accumulate in G₀/G₁ and undergo alterations in cell surface marker expression, cellular morphology and immunoglobulin production, all consistent with plasmacytoid differentiation. In contrast, B cells infected with EBV continued to proliferate and retained a blast-like phenotype. Differences in both cytokine production and the expression of cell cycle regulators were identified between the two B-cell populations, which might contribute to the differentiation of the CD40L/IL-4-stimulated B cells and suggest potential mechanisms by which EBV may overcome this. The study has also identified a window of opportunity during which a comparison of isogenic populations of EBV- and mitogen-driven B blasts can be made.

This article has been cited by other articles:

				S. Chaganti, E. M. Heath, W. Bergler, M. Kuo, M. Buettner, G. Niedobitek, A. B. Rickinson, and A. I. Bell Epstein-Barr virus colonization of tonsillar and peripheral blood B-cell subsets in primary infection and persistence Blood, June 18, 2009; 113(25): 6372 - 6381. [Abstract] [Full Text] [PDF]

				P. Young, E. Anderton, K. Paschos, R. White, and M. J. Allday Epstein-Barr virus nuclear antigen (EBNA) 3A induces the expression of and interacts with a subset of chaperones and co-chaperones J. Gen. Virol., April 1, 2008; 89(4): 866 - 877. [Abstract] [Full Text] [PDF]

				J. O'Nions, A. Turner, R. Craig, and M. J. Allday Epstein-Barr Virus Selectively Deregulates DNA Damage Responses in Normal B Cells but Has No Detectable Effect on Regulation of the Tumor Suppressor p53 J. Virol., December 15, 2006; 80(24): 12408 - 12413. [Abstract] [Full Text] [PDF]

				N. Syed, P. Smith, A. Sullivan, L. C. Spender, M. Dyer, L. Karran, J. O'Nions, M. Allday, I. Hoffmann, D. Crawford, et al. Transcriptional silencing of Polo-like kinase 2 (SNK/PLK2) is a frequent event in B-cell malignancies Blood, January 1, 2006; 107(1): 250 - 256. [Abstract] [Full Text] [PDF]